Risk of sequelae after Chlamydia trachomatis genital infection in women
- PMID: 20470050
- DOI: 10.1086/652395
Risk of sequelae after Chlamydia trachomatis genital infection in women
Abstract
Chlamydia trachomatis infection, the most common reportable disease in the United States, can lead to pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. Although C. trachomatis is identified among many women who receive a diagnosis of PID, the incidence and timing of PID and long-term sequelae from an untreated chlamydial infection have not been fully determined. This article examines evidence reviewed as part of the Centers for Disease Control and Prevention Chlamydia Immunology and Control Expert Advisory Meeting; 24 reports were included. We found no prospective studies directly assessing risk of long-term reproductive sequelae, such as infertility, after untreated C. trachomatis infection. Several studies assessed PID diagnosis after untreated chlamydial infection, but rates varied widely, making it difficult to determine an overall estimate. In high-risk settings, 2%-5% of untreated women developed PID within the approximately 2-week period between testing positive for C. trachomatis and returning for treatment. However, the rate of PID progression in the general, asymptomatic population followed up for longer periods appeared to be low. According to the largest studies, after symptomatic PID of any cause has occurred, up to 18% of women may develop infertility. In several studies, repeated chlamydial infection was associated with PID and other reproductive sequelae, although it was difficult to determine whether the risk per infection increased with each recurrent episode. The present review critically evaluates this body of literature and suggests future research directions. Specifically, prospective studies assessing rates of symptomatic PID, subclinical tubal damage, and long-term reproductive sequelae after C. trachomatis infection; better tools to measure PID and tubal damage; and studies on the natural history of repeated chlamydial infections are needed.
Similar articles
-
Acute pelvic inflammatory disease.Urol Clin North Am. 1984 Feb;11(1):65-81. Urol Clin North Am. 1984. PMID: 6369707 Review.
-
Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?J Infect Dis. 2010 Jun 15;201 Suppl 2:S156-67. doi: 10.1086/652396. J Infect Dis. 2010. PMID: 20470051 Review.
-
Chlamydia trachomatis: impact on human reproduction.Hum Reprod Update. 1999 Sep-Oct;5(5):433-47. doi: 10.1093/humupd/5.5.433. Hum Reprod Update. 1999. PMID: 10582782 Review.
-
Acute pelvic inflammatory disease.Semin Adolesc Med. 1986 Jun;2(2):143-53. Semin Adolesc Med. 1986. PMID: 3602634
-
Enzyme immunoassay in the diagnosis of Chlamydia trachomatis infections in diverse patient groups.J Hyg Epidemiol Microbiol Immunol. 1989;33(2):189-97. J Hyg Epidemiol Microbiol Immunol. 1989. PMID: 2671155
Cited by
-
Animal models for studying female genital tract infection with Chlamydia trachomatis.Infect Immun. 2013 Sep;81(9):3060-7. doi: 10.1128/IAI.00357-13. Epub 2013 Jul 8. Infect Immun. 2013. PMID: 23836817 Free PMC article. Review.
-
Evaluation of Chlamydia trachomatis screening from the perspective of health economics: a systematic review.Front Public Health. 2023 Oct 10;11:1212890. doi: 10.3389/fpubh.2023.1212890. eCollection 2023. Front Public Health. 2023. PMID: 37881345 Free PMC article.
-
Association between serum chlamydial antibody levels and tubal infertility in tertiary health facility in South-East Nigeria: a case-control study.Ghana Med J. 2021 Sep;55(3):183-189. doi: 10.4314/gmj.v55i3.2. Ghana Med J. 2021. PMID: 35950174 Free PMC article.
-
The role of Chlamydia trachomatis polymorphic membrane proteins in inflammation and sequelae among women with pelvic inflammatory disease.Infect Dis Obstet Gynecol. 2011;2011:989762. doi: 10.1155/2011/989762. Epub 2011 Oct 19. Infect Dis Obstet Gynecol. 2011. PMID: 22028586 Free PMC article.
-
Time series analysis and forecasting of chlamydia trachomatis incidence using surveillance data from 2008 to 2019 in Shenzhen, China.Epidemiol Infect. 2020 Mar 17;148:e76. doi: 10.1017/S0950268820000680. Epidemiol Infect. 2020. PMID: 32178748 Free PMC article.